United States President's Emergency Plan for AIDS Relief
12
3
3
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
8%
1 trials in Phase 3/4
13%
1 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
UNCPM 22314 - Pregnancy, Infant and Maternal Health Outcomes Study
Role: collaborator
PathToScale: The PERSIST Trial
Role: collaborator
Impact on Linkage to HIV Care With Point of Care CD4 Testing and Home-based HIV Testing in Kenya
Role: collaborator
PathToScale: An Implementation Evaluation
Role: collaborator
Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLD
Role: collaborator
Kenya Enhanced Mentor Mother ProgrAm (EMMA)
Role: collaborator
Sustainable East Africa Research in Community Health
Role: collaborator
Evaluation of an Enhanced Tuberculosis Infection Control Intervention in Healthcare Facilities in Vietnam and Thailand
Role: collaborator
Evaluation of Pre-Exposure Prophylaxis for High Risk Adolescent Girls and Young Women
Role: collaborator
Multidisciplinary Services to Enhance HIV Testing and Linkage to Care Among MSM
Role: collaborator
Tuberculosis Recurrence Upon Treatment With Highly Active Antiretroviral Therapy
Role: collaborator
Longitudinal Study of HAART, Social Networks, & Adherence
Role: collaborator
All 12 trials loaded